Study on the prevention of shivering and traction pain after cesarean section anesthesia by nalbuphine and pentazocine

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100054224

Enrollment

Unknown

Registered

2021-12-11

Start date

2022-02-01

Completion date

Unknown

Last updated

2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shivering and traction pain after cesarean section anesthesia

Interventions

Group N:Nalbuphine

Group P:Pentazocine

Group DN:Dexmedetomidine and nalbuphine

Group DP:Dexmedetomidine and pentazocine

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients who understood the content of this study and signed corresponding informed consent for full term cesarean section; 2. Aged > 18 years; 3. Weight 55-85 kg.

Exclusion criteria

Exclusion criteria: 1. Contraindications of spinal anesthesia; 2. Thyroid disease; 3. Gestational hypertension; 4. Placental abruption and placenta previa; 5. Multiple pregnancy; 6. Fetal distress; 7. Allergic to the test drug; 8. The person with high mental tension; 9. Abnormal heart, brain, liver, lung and kidney function.

Design outcomes

Primary

Measure	Time frame
Shivering classification;Traction pain classification;	—

Secondary

Measure	Time frame
Blood pressure;Heart rate;Pulse oxygen saturation;Degree of sedation;	—

Countries

China

Contacts

Public ContactZhao Panpan

Xuzhou First People's Hospital

994194039@qq.com+86 15152118630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026